Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 21% ± 7% | |
fibroblast | 10 studies | 23% ± 9% | |
pericyte | 7 studies | 21% ± 5% | |
macrophage | 6 studies | 23% ± 5% | |
plasma cell | 5 studies | 28% ± 12% | |
conventional dendritic cell | 4 studies | 26% ± 9% | |
connective tissue cell | 4 studies | 34% ± 18% | |
plasmablast | 3 studies | 40% ± 14% | |
classical monocyte | 3 studies | 22% ± 5% | |
abnormal cell | 3 studies | 20% ± 4% | |
capillary endothelial cell | 3 studies | 18% ± 3% | |
epithelial cell | 3 studies | 17% ± 1% | |
dendritic cell | 3 studies | 31% ± 3% | |
microglial cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1061.45 | 578 / 578 | 100% | 17.63 | 1152 / 1155 |
breast | 100% | 919.15 | 459 / 459 | 99% | 14.22 | 1104 / 1118 |
thymus | 100% | 894.58 | 653 / 653 | 99% | 21.33 | 596 / 605 |
uterus | 100% | 766.08 | 170 / 170 | 98% | 19.47 | 452 / 459 |
adrenal gland | 100% | 580.83 | 258 / 258 | 98% | 17.97 | 225 / 230 |
kidney | 100% | 531.31 | 89 / 89 | 97% | 37.26 | 876 / 901 |
ovary | 100% | 519.98 | 180 / 180 | 96% | 11.47 | 414 / 430 |
bladder | 100% | 793.95 | 21 / 21 | 96% | 14.83 | 483 / 504 |
esophagus | 98% | 442.61 | 1412 / 1445 | 96% | 13.20 | 175 / 183 |
prostate | 100% | 549.18 | 244 / 245 | 88% | 6.72 | 441 / 502 |
intestine | 98% | 522.70 | 950 / 966 | 86% | 9.17 | 454 / 527 |
pancreas | 82% | 212.04 | 269 / 328 | 97% | 14.28 | 173 / 178 |
stomach | 80% | 293.89 | 287 / 359 | 91% | 9.86 | 260 / 286 |
skin | 76% | 2419.94 | 1380 / 1809 | 94% | 22.99 | 444 / 472 |
liver | 81% | 336.33 | 182 / 226 | 89% | 10.04 | 361 / 406 |
brain | 54% | 135.96 | 1436 / 2642 | 79% | 10.19 | 554 / 705 |
adipose | 100% | 1225.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.73 | 29 / 29 |
spleen | 100% | 936.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.59 | 1 / 1 |
blood vessel | 100% | 906.24 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 488.75 | 808 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1205.07 | 858 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 5.27 | 45 / 80 |
muscle | 34% | 80.38 | 277 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010165 | Biological process | response to X-ray |
GO_0005730 | Cellular component | nucleolus |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | IKBIP |
Protein name | Inhibitor of nuclear factor kappa-B kinase-interacting protein (I kappa-B kinase-interacting protein) (IKBKB-interacting protein) (IKK-interacting protein) |
Synonyms | IKIP |
Description | FUNCTION: Target of p53/TP53 with pro-apoptotic function. . |
Accessions | ENST00000342502.6 [Q70UQ0-1] ENST00000299157.5 [Q70UQ0-4] Q70UQ0 ENST00000393042.3 [Q70UQ0-3] |